ARCHIVES

Nature Editorial Criticizes NCI PR Spending

This article is from The Cancer Letter archive.

Vol. 39 No. 11 | March 15, 2013

Download PDF Visit The Full Archive

Related Articles

It’s Official: House Appropriations Committee Gives NCI $81 Million Increase OverPresident’s Request

September 23, 1983

FDA Approives Lilly’s Alimta For 1st-Line Metastatic NSCLC

September 26, 2008

Interview: “People don’t understand Clinical Trials.

September 5, 1997

NCI prepares for third hearing on conflicts of interest.

June 18, 2004

Shingleton To Retire As Director Of Duke Comprehensive Center

July 10, 1981

In Brief: Gene Therapy Pioneer Michael Blaese To Leave NIH For Biotechnology Firm

January 23, 1998